Last reviewed · How we verify

NCT06654843: FT4W2+

Free Time For Wellness 2+

Recruiting now NA Last updated 12 November 2025
What this trial tests

NA trial testing Comparator Arm in Physical Inactivity in 630 participants. Currently enrolling.

Timeline
15 November 2024
Primary endpoint
30 September 2026
31 December 2026

Quick facts

Lead sponsorColumbia University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment630
Start date15 November 2024
Primary completion30 September 2026
Estimated completion31 December 2026
Sites10 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Columbia University

Who can join

18 and older, any sex, with Physical Inactivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Physical inactivity is pervasive and prevalent in the United States, particularly among women of low socioeconomic position, and women with children. Structural and social barriers make active leisure time a rare commodity creating a pressing health issue because physical inactivity increases the risk of chronic diseases and poor health. The broad objective of this study is to test the effectiveness of Free Time for Wellness (FT4W), an innovative multilevel physical activity intervention to increase physical activity among low-resourced mothers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Comparator Arm

Trials testing the same drug.

Other recruiting trials for Physical Inactivity

Currently open trials in the same condition.

Other Columbia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06654843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing